1. "2003"
Formats
  1. Journal Article (1307)
  2. Meeting Abstract (493)
  3. Book Section (121)
  4. Conference Paper (13)
  5. Book Whole (8)
Groups
  1. Department of Medicine (530)
  2. Sloan Kettering Institute Faculty (484)
  3. GSK Faculty (459)
  4. Surgery (454)
  5. Molecular Pharmacology and Chemistry Program Faculty (302)
  6. Solid Tumor Oncology Division (245)

More Groups

People
  1. Steven Larson (53)
  2. Michael Kattan (52)
  3. Carlos Cordon-Cardo (38)
  4. Murray Brennan (37)
  5. Peter Scardino (35)
  6. David Klimstra (34)

More People

Years
  1. 2003 (1942)
Publications
  1. Blood (97)
  2. Journal of Clinical Oncology (64)
  3. Journal of Nuclear Medicine (53)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (53)
  5. Modern Pathology (47)
  6. Laboratory Investigation (44)

More Publications

Publishers
  1. Elsevier Inc. (182)
  2. American Association for Cancer Research (137)
  3. Elsevier Science, Inc. (126)
  4. Lippincott Williams & Wilkins (117)
  5. Nature Publishing Group (113)
  6. Springer (98)

More Publishers

Results (1942)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early treatment with epoetin alfa improves anemia, quality of life (QOL), and productivity in patients (Pts) with hematologic malignancies and mild anemia during chemotherapy (CT)
    Meeting Abstract

    Straus, D. J.; Testa, M.; Riggs, S. A.; Tulpule, A.; Sarokhan, B.
    Blood (2003)

    Fulltext@MSK | Save
  • Grief reactions in relatives of cancer patients
    Meeting Abstract

    Straker, N.
    Psycho-Oncology (2003)

    Fulltext@MSK | Save
  • Insulin-like growth factor-1 (IGF-1), IGF-2, and the IGF binding proteins are differentially expressed by anaplastic and differentiated thyroid cancers
    Meeting Abstract

    Straight, A. M.; Patel, A.; Saji, M.; Ringel, M.; Tuttle, R. M.; Francis, G.
    Pediatric Research (2003)

    Fulltext@MSK | Save
  • Aplidine reduces angiogenic gene expression and increases PARP hydrolysis in anaplastic thyroid cancer xenografts
    Meeting Abstract

    Straight, A. M.; Patel, A.; Bauer, A.; Terrell, R.; Helms, A.; Tuttle, M.; Jimeno, J.; Saji, M.; Ringel, M.; Francis, G.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Positive selection and lineage commitment in the thymus
    Meeting Abstract

    Stolzer, A. L.; Vargas, L.; Sant'angelo, D. B.
    FASEB Journal (2003)

    Fulltext@MSK | Save
  • Residual mesorectal lymph node, involvement following neoadjuvant therapy: Rationale for radical resection?
    Meeting Abstract

    Stipa, F.; Minsky, B.; Weiser, M.; Paty, P.; Wong, W. D.; Guillem, J.
    Annals of Surgical Oncology (2003)

    Fulltext@MSK | Save
  • Local excision of rectal cancer with TEM
    Meeting Abstract

    Stipa, F.; Lucandri, G.; Ferri, M.; Ziparo, V.
    Annals of Surgical Oncology (2003)

    Fulltext@MSK | Save
  • Minimally invasive in vivo imaging of an oncolytic herpes simplex virus mutant expressing green fluorescent protein
    Meeting Abstract

    Stiles, B. M.; Adusumilli, P.; Bhargava, A.; Stanziale, S. F.; Wong, R. J.; Rusch, V. W.; Fong, Y. M.
    Molecular Therapy (2003)

    Fulltext@MSK | Save
  • Certification and licensing issues in medical health physics
    Meeting Abstract

    St. Germain, J.
    Health Physics (2003)

    Fulltext@MSK | Save
  • Phase 1 dose escalating and pharmacokinetic (PK) study of KOS-862 (epothilone D): Phase 2 dose and schedule defined
    Meeting Abstract

    Spriggs, D.; Dupont, J.; Pezzulli, S.; Larkin, J.; Cropp, G.; Johnson, R.; Hannah, A. L.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save